Collaboration on diagnostic test to improve prostate cancer screening
Thermo Fisher Scientific and Karolinska Institute reduce need for biopsies
11-Nov-2015 -
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the results of its collaboration with the Karolinska Institute on a groundbreaking clinical study, called Stockholm 3 (STHLM3), aimed at developing a more effective test for prostate cancer than using the ...
diagnostics
genetic markers
oncology
+3